Latest California Healthline Stories
Tras Uvalde, cirujanos de trauma detallan los horrores de las masacres, y reclaman cambios
En estos años, la profesión médica ha desarrollado técnicas como la rápida evacuación de pacientes para salvar a un mayor número de víctimas de tiroteos. Pero traumatólogos cirujanos entrevistados por KHN dicen que incluso esas mejoras solo pueden salvar a una fracción de los pacientes cuando son heridas infligidas por rifles de tipo militar.
KHN’s ‘What the Health?’: Taking a Shot at Gun Control
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
Lawmaker Takes on Insurance Companies and Gets Personal About His Health
State Sen. Scott Wiener opens up about a weeklong stint in the hospital last year and what it’s like to live with Crohn’s disease. The San Francisco Democrat is pushing a bill that would require insurance companies to cover certain medications while patients appeal denials.
Misinformation Clouds America’s Most Popular Emergency Contraception
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation’s most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
With its latest venture into primary care clinics, is America’s leading organization for seniors selling its trusted seal of approval?
California Wants to Slash Insulin Prices by Becoming a Drugmaker. Can it Succeed?
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
California quiere producir su propia insulina para bajar su alto costo, ¿lo conseguirá?
La administración del gobernador Gavin Newsom señaló que aproximadamente 4 millones de californianos han sido diagnosticados con diabetes, una enfermedad que puede destruir órganos, la vista y llevar a amputaciones si no se controla. La meta es prevenirlo con insulina más económica.
Despite a First-Ever ‘Right-to-Repair’ Law, There’s No Easy Fix for Wheelchair Users
Colorado lawmakers approved a measure that will make it easier for people to fix their power wheelchairs when they wear out or break down, but arcane regulations and manufacturers create high hurdles for nationwide reform.
Montana Hires a Medicaid Director With a Managed-Care Past
Montana, one of about a dozen states still managing its own Medicaid programs, has a new Medicaid director who championed handing the management of the program to private companies in Iowa and Kansas.
‘An Arm and a Leg’: Private Equity Is Everywhere in Health Care. Really.
Private equity companies are the house-flippers of the investment world, and they’ve found their way into many areas of our lives — including your local gastroenterologist’s office.